Document ID: chunk:federal_register_of_legislation:F2023L01670:clause:1_1
Version: federal_register_of_legislation:F2023L01670
Segment Type: clause
Provision Reference: sch 1 cl 1
Character Range: 2095–2841

1  Schedule 1 (cell at item 38495, column 2)
Repeal the cell, substitute:
       TAVI, for the treatment of symptomatic severe aortic stenosis, performed via transfemoral delivery, unless transfemoral delivery is contraindicated or not feasible, if:
       (a) the TAVI Patient is at high risk for surgery; and
       (b) the service:
            (i) is performed by a TAVI Practitioner in a TAVI Hospital; and
            (ii) includes all intraoperative diagnostic imaging that the TAVI Practitioner performs upon the TAVI Patient; and
            (iii) includes valvuloplasty, if required;
       not being a service which has been rendered within 5 years of a service to which this item or item 38514 or 38522 applies (H) (Anaes.) (Assist.)